Skip to content

Clinical trials

Neuroectodermal Tumors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20141
20151
20162
20173
20192
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
DNAtrix, Inc.2
M.D. Anderson Cancer Center2
BeiGene USA, Inc.1
Boehringer Ingelheim1
Gradalis, Inc.1
Hoffmann-La Roche1
Jazz Pharmaceuticals1
Jubilant DraxImage Inc.1
Masonic Cancer Center, University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors17
Neoplasms8
Brain Neoplasms7
Neoplasms by Histologic Type6
Sarcoma6
Central Nervous System Neoplasms5
Glioblastoma5
Glioma5
Gliosarcoma5
Neoplasms by Site5

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.